re: Generation

January 10, 2020

What makes Generation Bio unique? Hear from our team.

by GEOFF MCDONOUGH, MD, PRESIDENT & CHIEF EXECUTIVE OFFICER

Town Hall gathering

At Generation Bio, we believe that culture is shaped by everyone in our community — each employee using their unique skills, experiences and personality to help us achieve our collective mission. We view each new employee as bringing their own superpower to the team, enabling us to do something we couldn’t do before or see something from a new perspective. Because we value this emergent culture so highly, we are always taking steps to foster an environment where people can thrive and succeed, and feel comfortable being themselves.

From organizing our open-air seating into planful neighborhoods of cross-sectional employees, to gathering together for weekly, company-wide town halls, to our Friday morning tradition of disco dance parties, we’ve created a truly unique community and culture at Generation Bio that strikes a balance between hard work and fun. Check out the video below to hear from our employees about our culture — and consider joining our generation!

Safe Harbor Statement: Any statements in this Blog about our future expectations, plans and prospects, including statements relating to about our strategic plans or objectives, our technology platforms, our research and clinical development plans, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties inherent in the identification and development of product candidates, including the conduct of research activities; the initiation and completion of preclinical studies and clinical trials and clinical development of any product candidates; whether results from preclinical studies will be predictive of the results of later preclinical studies and clinical trials; expectations for regulatory approvals to conduct trials or to market products; challenges in the manufacture of genetic medicine products; our ability to obtain sufficient cash resources to fund our foreseeable and unforeseeable operating expenses and capital expenditure requirements; and the impact of the COVID-19 pandemic on our business and operations; as well as the other risks and uncertainties set forth in the “Risk Factors” section of our annual report on Form 10-K, as updated by our most recent quarterly report on Form 10-Q, which are on file with the Securities and Exchange Commission, and in any subsequent filings we may make with the Securities and Exchange Commission. In addition, the forward-looking statements included in this Blog represent our views as of the date hereof. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date on which they were made.

Take a seat at the table.

We are always looking for those who are ready to share their vision, talent, and tenacity—who believe in our mission and themselves.

Imagine a world without genetic disease.

What do you see? More health? Fewer doctor appointments? More bike riding? More peanut butter and jelly sandwiches? More life?
See our shared vision.
cross